AlphaCentric Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,250
| Closed | -$2.24M | – | 280 |
|
|
2024
Q3 | $2.24M | Sell |
6,250
-8,250
| -57% | -$2.96M | 1.67% | 14 |
|
|
2024
Q2 | $4.62M | Sell |
14,500
-1,500
| -9% | -$478K | 3.4% | 1 |
|
|
2024
Q1 | $3.68M | Buy |
+16,000
| New | +$3.68M | 2.22% | 4 |
|
|
2023
Q4 | – | Sell |
-9,000
| Closed | -$2.03M | – | 282 |
|
|
2023
Q3 | $2.03M | Hold |
9,000
| – | – | 1.15% | 26 |
|
|
2023
Q2 | $1.99M | Buy |
9,000
+5,500
| +157% | +$1.21M | 1.1% | 26 |
|
|
2023
Q1 | $784K | Buy |
3,500
+1,250
| +56% | +$280K | 0.54% | 66 |
|
|
2022
Q4 | $626K | Hold |
2,250
| – | – | 0.62% | 60 |
|
|
2022
Q3 | $471K | Buy |
+2,250
| New | +$471K | 0.48% | 59 |
|
|
2021
Q4 | $238K | Buy |
1,100
+550
| +100% | +$119K | 0.07% | 96 |
|
|
2021
Q3 | $102K | Hold |
550
| – | – | 0.03% | 163 |
|
|
2021
Q2 | $99K | Hold |
550
| – | – | 0.03% | 172 |
|
|
2021
Q1 | $92K | Sell |
550
-200
| -27% | -$33.5K | 0.03% | 162 |
|
|
2020
Q4 | $114K | Sell |
750
-76
| -9% | -$11.6K | 0.05% | 109 |
|
|
2020
Q3 | $83K | Buy |
+826
| New | +$83K | 0.04% | 71 |
|